The “GlucoBand”-New Non-Invasive Continuous Blood Glucose Monitor- A revolutionary glucose level measuring and monitoring device for diabetics will become available next year in Armenia, and its Armenian inventor hopes it will find broad application in Armenia, where diabetes is a wide-spread health risk. The Glucoband is the latest development of …

Using nanotechnology, researchers have created a human nephron filter, the first step toward development of fully functioning artificial kidney for patients with end-stage renal disease, possibly eliminating the need for dialysis or kidney transplantation.

Biofeedback-assisted relaxation seems to have a positive effect in patients with type 2 diabetes, leading to significant decreases in blood sugar levels.

The first Global Guidelines for Type 2 Diabetes were issued by the International Diabetes Federation (IDF), and they call for a more aggressive treatment target than the American Diabetes Association guidelines’ goal.

For patients with type 2 diabetes and a history of heart disease, the oral thiazolidinedione Actos (pioglitazone) was associated in a major trial with a 16% reduction in risk of death or recurrent heart attack.

Two weeks of daily treatments normalize the blood-glucose levels for up to 10 weeks after treatment ends, in addition to increasing beta cell mass 3-fold.

The investigators concluded that, in patients with type 2 diabetes not treated with insulin, self-monitoring did not predict better glycemic control over 3 years.

The results from 2 Phase II studies show that sitagliptin a new class diabetes drugs called DPP-4 inhibitors, improved glycemic control with no significant weight gain and low risk of hypoglycemia.

Patients who present with idiopathic neuropathy may in fact be experiencing the first signs of impaired glucose tolerance (IGT or “prediabetes”).

A sub-set of analysis from a clinical trial demonstrates that adding daily supplementation with Diachrome to prescription treatment regimens can significantly improve glycemic control in poorly controlled blood sugar levels in people with type 2 diabetes.